Where does Abraxis BioScience, LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abraxis BioScience, LLC ranks #6,612 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abraxis BioScience, LLC hold?

Abraxis BioScience, LLC holds 50 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is Abraxis BioScience, LLC's Innovation Score?

Abraxis BioScience, LLC has an Innovation Score of 41.3 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Abraxis BioScience, LLC focus on?

Abraxis BioScience, LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 50 patents, ranking #432 of 7,163 assignees active in that subclass. Grants appear in 12 CPC subclasses total.

Is Abraxis BioScience, LLC's patent grant rate increasing or decreasing?

Abraxis BioScience, LLC's recent grant velocity is -64% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Abraxis BioScience, LLC's patents?

Abraxis BioScience, LLC's patents average 21.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abraxis BioScience, LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Abraxis BioScience, LLC

USPTO PatentsView assignee record - 50 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abraxis ranks #6,612 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 12 technology areas.

#6,612
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.3/100): 21.2
avg claims per patent: -64%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6612 · US Corporation #6,612 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 50 grants
UPPER-Q #6,612/49,997
PHOTO-FINISH Ablative Solutions
CPC-FOCUS A61K · 12 areas
INNOV-PAR 41.3/100
CLAIMS-DENSE 21.2 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -64% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Ablative Solutions, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abraxis’s 41.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (33%) Velocity 2.8 pts (7%) Breadth 12.2 pts (30%) Claim depth 12.7 pts (31%)

Qualcomm Incorporated · highest

85
Abraxis BioScience · this assignee

41
ABT · near

41
AcuFocus · near

41
BOE (Hebei) Mobile… · near

41
Sisvel Technology S… · near

41
3D Lighting… · lowest

7

What this shows Abraxis's Innovation Score is 41.3/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abraxis?

Each dot is one of Abraxis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abraxis’s own 21.2 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abraxis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abraxis's grants concentrate

Abraxis BioScience, LLC is a focused PatentsView assignee: 12 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2015 (10 grants) versus a trough of 2 in 2021. By volume, Abraxis sits between Asco Power Technologies, L.P. and Beijing Youzhuju Network Technology Co., Ltd..

Abraxis's three-year grant acceleration

Abraxis BioScience, LLC shows 5 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Asco Power

50
Avintiv Specialty…

50
Axell

50
Ablative Solutions

50
Akzenta Paneele +…

50
Alentic Microscie…

50
Altor Bioscience

50
Beijing Youzhuju…

50
Abraxis Bioscience ◀

50

What this shows Abraxis holds 50 patents at rank #6,620, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abraxis

By rank, the assignees closest to #6,620 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Abraxis's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abraxis, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Abraxis ranks #432 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (41 here).

BOE (Hebei) Mobile Display Technology Co., Ltd. 41 Sisvel Technology S.R.L. 41 ABT, Inc. 41 AcuFocus, Inc. 41

Similar claim depth

Nearest assignees by average claims per patent (21.2 here).

CreeLED, Inc. 21.2 avg Idex Health & Science LLC 21.2 avg ROM Technologies, Inc. 21.2 avg NKT Photonics A/S 21.2 avg

Abraxis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

41 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Abraxis BioScience, LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	10	20.0%
2016	10	20.0%
2017	7	14.0%
2018	5	10.0%
2019	4	8.0%
2020	6	12.0%
2021	2	4.0%
2022	2	4.0%
2024	3	6.0%
2025partial year	1	2.0%

Which technologies does Abraxis BioScience, LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 50

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 43

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 15

C07K - Peptides 9

Y10S - Technical Subjects Covered BY Former Uspc Cross-reference ART Collections [XRACs] AND Digests 6

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 4

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 3

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 3

Y10T - Technical Subjects Covered BY Former US Classification 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 2

Y02A - Technologies FOR Adaptation TO Climate Change 1

Top 12 of 12 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abraxis BioScience, LLC's patent record in context - here's where to go next.

Abraxis BioScience, LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #6,612 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abraxis BioScience, LLC against Asco Power Technologies, L.P., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.